Skip to main content

Advertisement

Log in

The Genetics of Barrett’s Esophagus: A Familial and Population-Based Perspective

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Barrett’s esophagus (BE) is intestinal metaplasia of the lower esophagus and a precursor lesion for esophageal adenocarcinoma (EAC). Both are important health issues as they have rising incidences in the Western world. Improving the management of BE relies on understanding the underlying biology of this disease, but the exact biological mechanisms have been difficult to determine. BE is generally thought to be an acquired condition that develops secondarily to chronic gastroesophageal reflux. However, multiple reports of familial clustering of patients with BE and/or EAC suggest a possible inherited predisposition to BE may be driving this condition, at least in a subset of patients. Identifying the genetic variants that predispose to BE in these families would open up the possibility for blood-based screening tests that could inform decision-making in regard to surveillance strategies, particularly for relatives of patients with BE and/or EAC. Perhaps more importantly, understanding the genetic mechanisms that predispose to BE may provide valuable insights into the biology of this condition and potentially identify novel targets for therapeutic intervention. Here we review the current evidence for a genetic predisposition to BE and discuss the potential implications of these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fitzgerald RC. Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810–1820.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC. Barrett’s esophagus. J Gastroenterol Hepatol. 2011;26:639–648.

    Article  CAS  PubMed  Google Scholar 

  3. Groves C, Jankowski J, Barker F, Holdstock G. A family history of Barrett’s oesophagus: another risk factor? Scand J Gastroenterol. 2005;40:1127–1128.

    Article  PubMed  Google Scholar 

  4. Sappati Biyyani RS, Chessler L, McCain E, Nelson K, Fahmy N, King J. Familial trends of inheritance in gastro esophageal reflux disease, Barrett’s esophagus and Barrett’s adenocarcinoma: 20 families. Dis Esophagus. 2007;20:53–57.

    Article  CAS  PubMed  Google Scholar 

  5. Sun X, Elston R, Barnholtz-Sloan J, et al. A segregation analysis of Barrett’s esophagus and associated adenocarcinomas. Cancer Epidemiol Biomarkers Prev. 2010;19:666–674.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chak A, Ochs-Balcom H, Falk G, et al. Familiality in Barrett’s esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 2006;15:1668–1673.

    Article  PubMed  Google Scholar 

  7. Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett’s esophagus. Gastroenterology. 2010;138:854–869.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Nones K, Waddell N, Wayte N, et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun. 2014;5:5224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ross-Innes CS, Becq J, Warren A, et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma. Nat Genet. 2015;47:1038–1046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Stachler MD, Taylor-Weiner A, Peng S, et al. Paired exome analysis of Barrett’s esophagus and adenocarcinoma. Nat Genet. 2015;47:1047–1055.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wang KK, Sampliner RE. Updated guidelines for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.

    Article  PubMed  Google Scholar 

  12. American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American gastroenterological association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.

    Article  Google Scholar 

  13. Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus. Gut. 2006;55:442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Takubo K, Aida J, Naomoto Y, et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol. 2009;40:65–74.

    Article  PubMed  Google Scholar 

  15. Coleman HG, Bhat SK, Murray LJ, et al. Symptoms and endoscopic features at Barrett’s esophagus diagnosis: implications for neoplastic progression risk. Am J Gastroenterol. 2014;109:527–534.

    Article  PubMed  Google Scholar 

  16. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett’s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61:226–231.

    Article  PubMed  Google Scholar 

  17. Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett’s esophagus. Am J Epidemiol. 2005;162:454–460.

    Article  PubMed  Google Scholar 

  18. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670–1677.

    Article  PubMed  Google Scholar 

  19. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831.

    Article  PubMed  Google Scholar 

  20. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57:1354–1359.

    Article  CAS  PubMed  Google Scholar 

  21. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23:4541–4557.

    Article  Google Scholar 

  22. Kim JH, Rhee PL, Lee JH, et al. Prevalence and risk factors of Barrett’s esophagus in Korea. J Gastroenterol Hepatol. 2007;22:908–912.

    Article  PubMed  Google Scholar 

  23. Hongo M. Barrett’s oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004;20 Suppl 8:50–54.

    Article  PubMed  Google Scholar 

  24. Tseng PH, Lee YC, Chiu HM, et al. Prevalence and clinical characteristics of Barrett’s esophagus in a Chinese general population. J Clin Gastroenterol. 2008;42:1074–1079.

    Article  PubMed  Google Scholar 

  25. Dong Y, Qi B, Feng X-Y, Jiang C-M. Meta-analysis of Barrett’s esophagus in China. World J Gastroenterol. 2013;19:8770–8779.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chang C-Y, Cook MB, Lee Y-C, et al. Current status of Barrett’s esophagus research in Asia. J Gastroenterol Hepatol. 2011;26:240–246.

    Article  PubMed  PubMed Central  Google Scholar 

  27. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MCJM, Kuipers EJ. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54:1062–1066.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol. 2011;26:739–745.

    Article  PubMed  Google Scholar 

  29. Jung KW, Talley NJ, Romero Y, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol. 2011;106:1447–1455.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. NEJM. 2011;365:1375–1383.

    Article  CAS  PubMed  Google Scholar 

  31. Sikkema M, de Jonge PJF, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235–244.

    Article  PubMed  Google Scholar 

  32. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237–249.

    Article  PubMed  Google Scholar 

  33. de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort study. Gut. 2010;59:1030–1036.

    Article  PubMed  Google Scholar 

  34. Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61:970–976.

    Article  PubMed  Google Scholar 

  35. Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63:232–248.

    Article  PubMed  Google Scholar 

  36. Solaymani-Dodaran M, Logan RF, West J, Card T. Mortality associated with Barrett’s esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study. Am J Gastroenterol. 2005;100:2616–2621.

    Article  PubMed  Google Scholar 

  37. van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut. 1996;39:5–8.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Anderson LA, Murray LJ, Murphy SJ, et al. Mortality in Barrett’s oesophagus: results from a population based study. Gut. 2003;52:1081–1084.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572.

    Article  PubMed  Google Scholar 

  40. Sikkema M, Looman CWN, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106:1231–1238.

    Article  CAS  PubMed  Google Scholar 

  41. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67:394–398.

    Article  PubMed  Google Scholar 

  42. Bennett C, Vakil N, Bergman J, et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma. Based on a Delphi Process. Gastroenterology. 2012;143:336–346.

    Article  PubMed  Google Scholar 

  43. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23:3155–3162.

    Article  CAS  PubMed  Google Scholar 

  44. Wang DH, Souza RF. Biology of Barrett’s esophagus and esophageal adenocarcinoma. Gastrointest Endosc Clin N Am. 2011;21:25–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Everhart CW Jr, Holtzapple PG, Humphries TJ. Barrett’s esophagus: inherited epithelium or inherited reflux? J Clin Gastroenterol. 1983;5:357–358.

    Article  PubMed  Google Scholar 

  46. Crabb DW, Berk MA, Hall TR, Conneally PM, Biegel AA, Lehman GA. Familial gastroesophageal reflux and development of Barrett’s esophagus. Ann Intern Med. 1985;103:52–54.

    Article  CAS  PubMed  Google Scholar 

  47. Prior A, Whorwell PJ. Familial Barrett’s oesophagus? Hepatogastroenterology. 1986;33:86–87.

    CAS  PubMed  Google Scholar 

  48. Gelfand MD. Barrett esophagus in sexagenarian identical twins. J Clin Gastroenterol. 1983;5:251–253.

    Article  CAS  PubMed  Google Scholar 

  49. Eng C, Spechler SJ, Ruben R, Li FP. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 1993;2:397–399.

    CAS  PubMed  Google Scholar 

  50. Munitiz V, Parrilla P, Ortiz A, Martinez-de-Haro LF, Yelamos J, Molina J. High risk of malignancy in familial Barrett’s esophagus: presentation of one family. J Clin Gastroenterol. 2008;42:806–809.

    Article  PubMed  Google Scholar 

  51. Bresalier RS. Barrett’s esophagus and esophageal adenocarcinoma. Annu Rev Med. 2009;60:221–231.

    Article  CAS  PubMed  Google Scholar 

  52. Ash S, Vaccaro B, Dabney M, Chung W, Lightdale C, Abrams J. Comparison of endoscopic and clinical characteristics of patients with familial and sporadic Barrett’s esophagus. Dig Dis Sci. 2011;56:1702–1706.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Chak A, Chen Y, Vengoechea J, et al. Variation in age at cancer diagnosis in familial versus nonfamilial Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2012;21:376–383.

    Article  PubMed  Google Scholar 

  54. Verbeek R, Spittuler L, Peute A, et al. Familial clustering of Barretts esophagus and esophageal adenocarcinoma. [Abstract] Proceedings of 13th World Congress of the International Society of Disease of the Esophagus. Venice, Italy: Wiley Online; 2012. p. 38A. 2012 October 2012.

  55. Chak A, Lee T, Kinnard MF, et al. Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut. 2002;51:323–328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Chak A, Faulx A, Kinnard M, et al. Identification of Barrett’s esophagus in relatives by endoscopic screening. Am J Gastroenterol. 2004;99:2107–2114.

    Article  PubMed  Google Scholar 

  57. Drovdlic CM, Goddard KA, Chak A, et al. Demographic and phenotypic features of 70 families segregating Barrett’s oesophagus and oesophageal adenocarcinoma. J Med Genet. 2003;40:651–656.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology. 2002;122:633–640.

    Article  PubMed  Google Scholar 

  59. Chak A, Falk G, Grady WM, et al. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol. 2009;104:1913–1921.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Falk GW, Jacobson BC, Riddell RH, et al. Barrett’s esophagus: prevalence-incidence and etiology-origins. Ann N Y Acad Sci. 2011;1232:1–17.

    Article  CAS  PubMed  Google Scholar 

  61. Romero Y, Cameron AJ, Schaid DJ, et al. Barrett’s esophagus: prevalence in symptomatic relatives. Am J Gastroenterol. 2002;97:1127–1132.

    Article  PubMed  Google Scholar 

  62. Verbeek RE, Spittuler LF, Peute A, et al. Familial clustering of Barrett’s esophagus and esophageal adenocarcinoma in a European cohort. Clin Gastroenterol Hepatol. 2014;12:1656–1663.

    Article  PubMed  Google Scholar 

  63. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831.

    Article  PubMed  Google Scholar 

  64. Romero Y, Slusser JP, De Andrade M, et al. Evidence from linkage analysis for susceptibility genes in familial Barrett’s esophagus and esophageal adenocarcinoma. [Abstract]. Gastroenterology. 2006;130:A106.

    Article  Google Scholar 

  65. Orloff M, Peterson C, He X, et al. Germline mutations in MSR1, ASC1, and ATHRC1 in patients with Barrett’s esophagus and esophageal adenocarcinoma. JAMA. 2011;306:410–419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Fecteau R, Guda K, Markowitz S, et al. Identification of a novel germ-line variant in an uncharacterized gene, FBE-1, and its putative role in familial Barrett’s esophagus. [Abstract]. Gastroenterology. 2015;148:S-31.

    Article  Google Scholar 

  67. Su Z, Gay LJ, Strange A, et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus. Nat Genet. 2012;44:1131–1136.

    Article  CAS  PubMed  Google Scholar 

  68. Levine DM, Ek WE, Zhang R, et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett’s esophagus. Nat Genet. 2013;45:1487–1493.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. van Nistelrooij AMJ, van der Korput HAGM, Broer L, et al. Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma. J Carcinog. 2015;14:5.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D, Morrisey EE. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development. 2007;134:1991–2000.

    Article  CAS  PubMed  Google Scholar 

  71. Clemons N, Phillips W, Lord RVN. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastresophageal junction. Cancer Biol Ther. 2013;14:782–795.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Wang DH, Clemons NJ, Miyashita T, et al. Aberrant epithelial-mesenchymal hedgehog signaling characterizes Barrett’s metaplasia. Gastroenterology. 2010;138:1810–1822.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Wang DH, Tiwari A, Kim ME, et al. Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett’s metaplasia. J Clin Invest. 2014;124:3767–3780.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Jochem VJ, Fuerst PA, Fromkes JJ. Familial Barrett’s esophagus associated with adenocarcinoma. Gastroenterology. 1992;102:1400–1402.

    Article  CAS  PubMed  Google Scholar 

  75. Fahmy N, King JF. Barrett’s esophagus: an acquired condition with genetic predisposition. Am J Gastroenterol. 1993;88:1262–1265.

    CAS  PubMed  Google Scholar 

  76. Poynton AR, Walsh TN, O’Sullivan G, Hennessy TP. Carcinoma arising in familial Barrett’s esophagus. Am J Gastroenterol. 1996;91:1855–1856.

    CAS  PubMed  Google Scholar 

  77. Melzer E, Shtoyerman R, Appelman Z, Kashtan H. Familial Barrett’s adenocarcinoma. Am J Gastroenterol. 2006;101:677.

    Article  PubMed  Google Scholar 

  78. Farr C. Familial Barrett’s esophagus. Am J Gastroenterol. 2008;103:S216.

    Google Scholar 

  79. Casson AG, Zheng Z, Chiasson D, et al. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev. 2003;27:139–146.

    Article  CAS  PubMed  Google Scholar 

  80. Tarlarini C, Penco S, Conio M, Grossi E. Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett’s esophagus in a cohort of Italian subjects: a neural network analysis. Clin Exp Gastroenterol. 2012;5:159–166.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Menke V, Pot RGJ, Moons LMG, et al. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett’s esophagus and esophageal adenocarcinoma. J Hum Genet. 2012;57:26–32.

    Article  CAS  PubMed  Google Scholar 

  82. Kala Z, Dolina J, Marek F, Holla LI. Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett’s esophagus. J Hum Genet. 2007;52:527–534.

    Article  PubMed  Google Scholar 

  83. Menke V, van Zoest KPM, Moons LMG, et al. NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett’s esophagus and esophageal adenocarcinoma. Scand J Gastroenterol. 2012;47:378–386.

    Article  CAS  PubMed  Google Scholar 

  84. Babar M, Ryan AW, Anderson LA, et al. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2012;107:1331–1341.

    Article  CAS  PubMed  Google Scholar 

  85. Holla LI, Linhartova PB, Hrdlickova B, et al. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett’s esophagus. Hum Immunol. 2013;74:1161–1169.

    Article  Google Scholar 

  86. McElholm AR, McKnight AJ, Patterson CC, Johnston BT, Hardie LJ, Murray LJ. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology. 2010;139:204–212.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

HT was supported by the Foundation Scholarship from the Royal Australasian College of Surgeons (RACS) and a Postgraduate Research award from the Cancer Council of Victoria. WAP and NJC were supported, in part, by a National Health and Medical Research Council (NHMRC) of Australia Centres for Research Excellence Grant (1040947).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wayne A. Phillips.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

To, H., Clemons, N.J., Duong, C.P. et al. The Genetics of Barrett’s Esophagus: A Familial and Population-Based Perspective. Dig Dis Sci 61, 1826–1834 (2016). https://doi.org/10.1007/s10620-016-4109-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4109-2

Keywords

Navigation